Skyrocketing Prices of Insulin and Medicines Making Diabetes Management Unaffordable

According to a report by the Blue Circle Diabetes Foundation, 8.5% of Maharashtra’s population is affected by diabetes.
Skyrocketing Prices of Insulin and Diabetes Medicines
Skyrocketing Prices of Insulin and Diabetes MedicinesTBC
Published on

Pune: The rising cost of diabetes treatment is driving many families in Maharashtra into financial distress, with poor and middle-class households bearing the brunt.

According to a report by the Blue Circle Diabetes Foundation, 8.5% of Maharashtra’s population is affected by diabetes, and the skyrocketing prices of insulin, medicines, and glucose-monitoring devices are making it difficult for patients to manage their health.

Skyrocketing Prices of Insulin and Diabetes Medicines
Pune: Painex Clinic Introduces Regenerative Therapy for Diabetic Neuropathy

Escalating Medical Costs Affecting Families

Diabetes treatment involves lifelong expenses, including the cost of medications, insulin injections, glucose monitoring devices, and regular doctor consultations. The sharp rise in prices has made it increasingly difficult for families to afford essential diabetes care. Many patients, especially from economically weaker sections, struggle to maintain stable blood sugar levels due to financial constraints.

Skyrocketing Prices of Insulin and Diabetes Medicines
Thin Fat Indian to Epigenetics: New Frontiers in Diabetes Research Unveiled

The rising costs have also led to an increase in cases of uncontrolled diabetes, which can result in serious complications affecting the heart, kidneys, eyes, and other organs. If left untreated, these complications can put an enormous economic and social burden on the state.

Call for Government Intervention

Highlighting this critical issue, Nupur Lalwani and Snehal Nandgavli from the Blue Circle Diabetes Foundation have emphasized that healthcare is a fundamental right and should be affordable and accessible to all.

In a public statement, they have urged the authorities to implement price control measures on diabetes medications and medical equipment. They stressed the need for concrete policy changes to ensure that essential diabetes treatment remains within reach for all patients, regardless of their financial status.

Help Us Create the Content You Love

Take Survey Now!

Enjoyed reading The Bridge Chronicle?
Your support motivates us to do better. Follow us on Facebook, Instagram, Twitter and Whatsapp to stay updated with the latest stories.
You can also read on the go with our Android and iOS mobile app.

Related Stories

No stories found.
logo
The Bridge Chronicle
www.thebridgechronicle.com